We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Victor Mobility have designed a mobility device to bring a disabled person into an able bodied environment. The mobility device will be modular so it will adapt to the users disability, it will go up and down a kerb, it will go inside and out so you don't have to buy two devices and it will enable the user to be at social height or eye height of 1.5m.
days to go: Expired investment: £716,150
Untied is a groundbreaking app that gathers information, claims costs and allowances, and prepares tax filings on the go. All of these can be sent to the tax authority from the application. The app connects across existing accounts, making tax sense of transactions and gives the assurance someone needs. Backed by Accenture's Fintech Innovation Lab and Barclays Techstars, the company became the first overseas winner of Israel's biggest fintech prize at Fintech Junction. The business will earn a turn over of £100m in ten years making it ready for an IPO. With the proceeds, it will create new software platforms, publishers, banks, and accounting firms.
days to go: Expired investment: £350,000
Genomes.io is a safe and private DNA data storage application resolving the problem of DNA data breach and exploitation. It helps the users to store, manage, promote and arrange their genomic data in order. The company is a member of Consensys Labs Tachyon II Accelerator 2019. It has also signed MOU with TenX Health VC for lead investment and board position and, it is in discussions with Pharma & Biotech co for establishing partnerships. The company is seeking funds to bring its B2B and B2C products to market.

Pitch Rated

76%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,035,370
StanMe aims to be the first community marketplace to enable collaboration and co-selling between independent creators. It asserts that the majority of creators have to continuously learn techniques to market themselves, adapt to social platforms’ ever-changing algorithms, and grow and maintain a large community to generate a sufficient amount of sales. StanMe claims that not all can do so and intends to address this situation with its services. It launched its public beta in July 2020 with more than 1,000 users and has processed over 130 transactions since its beta launch. StanMe claims it has more than 1,900 pre-registered users on its waiting list and aspires to become a contender in the creator economy valued at $11 billion in 2019. It will use the investment to accelerate its growth, invest in technology, and boost marketing initiatives.

Pitch Rated

69%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £164,080
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform. 
days to go: Expired investment: £1,040,000
Bio Teq aim to be early movers in the human implantable technology market ebbedding micro-transponder technology into users hands. The company has already featured on BBC, Channel 5 and ITV News and is raising to further research and development.
days to go: Expired investment: £39,770
Currently, the self-employed have fewer admissions to financial services than their employed counterparts do. Hatch aims to give sole traders free-to-use access to real-time credit scores that will allow lenders to make more informed decisions when invoice funding. The company also offers digitising of tax files, one of the most time-consuming admin burdens. Revenue is generated via affiliate fees to those who wish to introduce and facilitate Hatch on their platforms. A beta for 5k users will be launching soon, with half the slots already filled.
days to go: Expired investment: £115,000
Love2move has developed a platform to bridge the gap between sellers/ homeowners and the market. It functions as an internet estate agent working in collaboration with well- established estate agents with a physical office. This way Love2move provides its users the best of both traditional as well as online estate agents. With the help of online sales platform, the agents can list homes without much setup costs involved.
days to go: Expired investment: £51,850
Using the latest in Internet of Things (IoT) and low-power technology, Sensize has created a system to globally monitor supply chains. Trackers are fitted to reusable plastic crates, containers, cages and palettes. They are used to alert theft, record their location and detect the environment as they are transported through a supply chain.
days to go: Expired investment: £149,240
The first wholesaler to offer insurance products for B2B and B2C firms in the Sharing Economy. Inlet aims provide insurance for assets that have been peer-to-peer rented for the short term, or for the provision of services such as letting properties online, as these markets are not currently covered by traditional insurances. Inlet generates revenue from commissions via insurance products at the point of sale and at policy renewal. Income in the form of interest payments is also earned from customers that choose to pay via direct debit on a monthly basis, as well as from fees applied to customers who wish to amend their policies.
days to go: Expired investment: £256,514
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph